At MIT's labs in Cambridge, Massachusetts, researchers have peeled away a layer of complexity from one of medicine's most vital interventions: the pacemaker. Instead of surgical implants that carry infection risk and battery replacement surgeries, they've created something far simpler — a postage-stamp-sized sticker worn on the chest that uses ultrasound to steady an irregular heartbeat.
The device represents a fundamental shift in how we might treat cardiac arrhythmias. Around 3 million American adults currently live with surgically implanted pacemakers, small battery-powered devices that deliver electrical impulses to regulate heart rate. These implants have saved millions of lives, yet they are inherently invasive, requiring surgery and direct contact with the beating heart. For decades, researchers dreamed of a gentler alternative. Now, MIT engineers led by Xuanhe Zhao, professor of mechanical engineering and civil and environmental engineering, have made that dream tangible.
The innovation combines two powerful approaches. First, the team harnessed sonogenetics — a genetic engineering technique modeled after optogenetics — to make heart cells hypersensitive to sound. They genetically altered heart cells so that ion channels on their surface would open more readily in response to ultrasound waves. When these channels open, calcium floods into the cell, triggering it to contract and beat. Separately, they designed tiny ultrasound transducers that can be embedded in a flexible sticker and programmed to send precisely timed pulses through the chest wall.
In laboratory experiments, the approach worked with striking consistency. When researchers exposed their genetically engineered human cardiac cells to ultrasound, the cells beat in perfect synchronization with the waves — a control that eluded previous attempts at ultrasound-based heart stimulation. The team then tested the sticker on living rats with induced arrhythmias. The device quickly and safely corrected the irregular rhythms, restoring normal contractions without any invasive procedure. The complete prototype, including the sticker itself and a pocket-sized device containing batteries and electronics, is already fabricated and functional.
What makes this breakthrough particularly elegant is its path to clinical use. Rather than requiring genetic modification of a patient's existing heart cells — an ethically complex proposition — the team envisions a one-time injection, similar to a vaccine, that would deliver the genetic changes directly to a patient's heart tissue. This same research group previously demonstrated an ultrasound sticker capable of deep-tissue imaging. They now plan to merge both capabilities into a single patch that could simultaneously monitor and regulate the heart's activity, creating what Zhao calls "a noninvasive closed-loop way" to manage cardiac health.
The findings, published today in Nature Biomedical Engineering, represent work by MIT researchers including first author Chen Gong, alongside Runze Li, Won Jun Song, and others, in collaboration with teams from the University of Southern California, Harvard University, and UCLA. The research stands at a threshold: years of animal testing and refinement remain before human trials, yet the proof of concept is undeniable. For millions of people who might one day avoid surgery altogether, the implications are profound. A sticker instead of a scar. Sound instead of steel. Medicine quietly moving toward gentleness.